Polymer scaffolds as drug delivery systems

Author(s)

Calori, Italo Rodrigo ^{[1, 2]} ; Braga, Gustavo ^[2] ; Carvalho de Jesus, Priscila da Costa ^[3] ; Bi, Hong ^[4] ; Tedesco, Antonio Claudio ^{[1, 4]}

Affiliation

^[1] Univ Sao Paulo, Fac Philosophy Sci & Letters Ribeirao Preto, Ctr Nanotechnol & Tissue Engn, Photobiol & Photomed Res Grp, Dept Chem, BR-14040901 Ribeirao Preto, SP - Brazil

^[2] Univ Estadual Maringa, Dept Chem, Res Nucleus Photodynam Syst, Av Colombo 5790, BR-97020900 Maringa, Parana - Brazil

^[3] Univ Sao Paulo, Polytech Sch, Av Prof Lineu Prates 580, Bldg Semiind Univ City, BR-05434070 Sao Paulo, SP - Brazil

^[4] Anhui Univ, Sch Chem & Chem Engn, Anhui Key Lab Modern Biomfg, Hefei 230601 - Peoples R China

• Document type: Review article
• Source: EUROPEAN POLYMER JOURNAL; v. 129, APR 15 2020.
• Web of Science Citations: 0

Abstract

Drug delivery scaffolds are smart alternatives to conventional formulations and allow for controlled spatio-temporal releases of active compounds. In several fields of human health, various methods have emerged with natural and synthetic polymers that make the fabrication of new polymer scaffolds possible. This review provides an overview of all recently published studies on the development and application of polymer scaffolds targeting controlled drug delivery in medicinal fields, including regenerative medicine and cancer therapy. The review includes a summary of the most common types of polymers used in drug release scaffolds, polymer scaffold classes, and the most common fabrication methods employed to develop such scaffolds. A detailed overview is provided concerning the strategies used to load drugs into scaffolds and their effects on drug release. A discussion about the strategies applied to modulate drug delivery is introduced. This details polymer blends and responsive releases that target the control of the drug delivery rate. In addition, current examples of their applications are provided. These include anti-inflammatory drugs and growth factors, as well as more recent in vitro and in vivo assays. Finally, future perspectives of these biomedical devices in clinical applications are presented. (AU)

• FAPESP's process: 13/50181-1 - Use of drugs containing nanocarriers with photosensitizers and/or other active compounds applied to cell therapy and treatment of central nervous system disorders
• Grantee: Antonio Claudio Tedesco
• Support Opportunities: Research Projects - Thematic Grants